PROTECT-CHILD Pediatric Transplant Data Implementation Guide, published by Protect Child. This guide is not an authorized publication; it is the continuous build for version 0.1.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/protect-child/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Kidney example — tacrolimus reduced for BK-virus nephropathy - XML Representation

Raw xml | Download

<MedicationStatement xmlns="http://hl7.org/fhir">
  <id value="KidneyImmPatReduced1"/>
  <meta>
    <profile
             value="https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/StructureDefinition/imm-pat"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationStatement KidneyImmPatReduced1</b></p><a name="KidneyImmPatReduced1"> </a><a name="hcKidneyImmPatReduced1"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-imm-pat.html">Immunosuppressant to Patient</a></p></div><p><b>identifier</b>: <a href="NamingSystem-NsProtectChildId.html" title="Single identifier namespace for PROTECT-CHILD record business identifiers (patient, donor, visit, transplant, and all per-visit clinical/lab/medication/specimen/event records). The resource type distinguishes the kind of record. Identifiers follow one convention: TOKEN-CENTRE-SEQUENCE, for example REC-1-0001 (patient, centre 1, sequence 1) or LBR-1-0006 (lab result); study-wide catalogue entries such as lab tests are not centre-qualified and use TOKEN-SEQUENCE, for example LBT-0001. Identifiers carry no clinical meaning.">ProtectChildId</a>/IMP-2-0003</p><p><b>status</b>: Active</p><p><b>category</b>: <span title="Codes:{https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/imm-pat-phase-cs maintenance}">Maintenance</span></p><p><b>medication</b>: <a href="Medication-ImmunosuppressantTacrolimus1.html">Medication CNI (FK506)</a></p><p><b>subject</b>: <a href="Patient-KidneyRecipient1.html">Anonymous Patient Male, DoB Unknown ( https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/NamingSystem/protect-child-id#ProtectChildId#REC-2-0001)</a></p><p><b>context</b>: <a href="Encounter-KidneyVisitRejection1.html">Encounter: identifier = https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/NamingSystem/protect-child-id#ProtectChildId#VIS-2-0003; status = finished; class = ambulatory (ActCode#AMB); type = Clinical Event visit; period = 2024-06-20 --&gt; 2024-06-20</a></p><p><b>effective</b>: 2024-06-20 --&gt; (ongoing)</p><blockquote><p><b>dosage</b></p><p><b>text</b>: Halved in response to biopsy-proven BK-virus nephropathy. Divided twice daily.</p><h3>DoseAndRates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Dose[x]</b></td></tr><tr><td style="display: none">*</td><td>0.05 mg/kg<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg.kg-1 = 'mg.kg-1')</span></td></tr></table></blockquote></div>
  </text>
  <identifier>
    <system
            value="https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/NamingSystem/protect-child-id"/>
    <value value="IMP-2-0003"/>
  </identifier>
  <status value="active"/>
  <category>
    <coding>
      <system
              value="https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/imm-pat-phase-cs"/>
      <code value="maintenance"/>
      <display value="Maintenance"/>
    </coding>
  </category>
  <medicationReference>🔗 
    <reference value="Medication/ImmunosuppressantTacrolimus1"/>
  </medicationReference>
  <subject>🔗 
    <reference value="Patient/KidneyRecipient1"/>
  </subject>
  <context>🔗 
    <reference value="Encounter/KidneyVisitRejection1"/>
  </context>
  <effectivePeriod>
    <start value="2024-06-20"/>
  </effectivePeriod>
  <dosage>
    <text
          value="Halved in response to biopsy-proven BK-virus nephropathy. Divided twice daily."/>
    <doseAndRate>
      <doseQuantity>
        <value value="0.05"/>
        <unit value="mg/kg"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg.kg-1"/>
      </doseQuantity>
    </doseAndRate>
  </dosage>
</MedicationStatement>